Milton Essex (WAR:MTN) Research & Development: zł0.00 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:MTN Milton Essex SA WAR:MTN
29 GF Score
Price zł0.73
GF Value zł0.13
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Milton Essex Research & Development?

Milton Essex WAR:MTN -1.36% 29 Research & Development is zł0.00 Mil as of Mar. 2026. GuruFocus rates WAR:MTN with a GF Score™ of 29/100 and a GF Value™ of zł0.13 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Milton Essex's Research & Development for the three months ended in Mar. 2026 was zł0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was zł0.00 Mil.

Milton Essex  (WAR:MTN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Milton Essex Research & Development Related Terms

Milton Essex Research & Development Historical Data

* Premium members only.

The historical data trend for Milton Essex's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Milton Essex Research & Development Chart

Milton Essex Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Milton Essex Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:MTN
29GF Score
Milton Essex SA WAR:MTN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Milton Essex Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of zł0.00 Mil mean?
Milton Essex (WAR:MTN) has a Research & Development of zł0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Milton Essex and its competitors.
Is Milton Essex's Research & Development too high?
Milton Essex's current Research & Development is zł0.00 Mil. Overall, Milton Essex has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Milton Essex's Research & Development compare to ABT and SYK?
Milton Essex's Research & Development of zł0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Milton Essex and its competitors. Milton Essex's current Research & Development is zł0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Milton Essex stock overvalued right now?
Based on GuruFocus' analysis, Milton Essex (WAR:MTN) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.13, compared to a current price of zł0.73 — trading 457.7% above its estimated fair value. The current Research & Development is zł0.00 Mil. Milton Essex's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Milton Essex (WAR:MTN), the current Research & Development is zł0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Milton Essex (WAR:MTN) Overvalued in 2026?

Based on GuruFocus' analysis, Milton Essex stock appears to be overvalued. The current stock price of zł0.73 is trading 457.7% above its estimated GF Value™ of zł0.13. GuruFocus considers Milton Essex to be Significantly Overvalued.

Key valuation signals for WAR:MTN:

  • Research & Development: zł0.00 Mil
  • GF Value™: zł0.13 vs. price of zł0.73 (457.7% above fair value)
  • GF Score™: 29/100 with 4 warning signs

No single metric tells the full story. See the WAR:MTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Milton Essex Business Description

Address ul. J. P. Woronicza 31/348, Warsaw, POL, 02-640
Milton Essex SA provides contact-free hybrid scanners for allergology and oncological dermatology. The products of the company include Ski Sense, FaceCov and InfraSkin.
29GF Score

Get the complete analysis for WAR:MTN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.73
Price
zł0.13
GF Value